Clinical Applications of Mifepristone: Assessing the Science and Recommending a Research Agenda - Couverture souple

Institute Of Medicine; Committee On Antiprogestins: Assessing The Science

 
9780309049498: Clinical Applications of Mifepristone: Assessing the Science and Recommending a Research Agenda

Synopsis

Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic role in human health and disease, with likely applicability to a variety of pregnancy-related conditions (e.g., management of labor) and to contraception, endometriosis, and cancer, among others. But because mifepristone has been studied and used most widely as a means of nonsurgical abortion, political issues have thus far limited research on the drug and prevented its introduction into the U.S. market.

This book provides an unbiased evaluation of current knowledge about both the fundamental nature of antiprogestins as well as their possible use in treating numerous diseases and conditions, and it contains recommendations for future research.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

À propos de l?auteur

Molla S. Donaldson, Laneta Dorflinger, Sarah S. Brown, and Leslie Z. Benet, Editors; Committee on Antiprogestins: Assessing the Science, Institute of Medicine

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.